|Year : 2019 | Volume
| Issue : 1 | Page : 44-49
Renal oxidative stress and inflammatory response in perinatal Cyclosporine-A exposed rat progeny and its relation to gender
Hany M El-Bassossy1, Mohammed A Hassanien2, Abdulhadi Bima3, Fatma M Ghoneim4, Ayman Zaky Elsamanoudy5
1 Department of Pharmacology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Pharmacology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
2 Assessment Centre and Medical Education Department, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia; Department of Medical Biochemistry, College of Medicine, Tanta University, Tanta, Egypt
3 Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
4 Department of Medical Histology and Cell Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
5 Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
|Date of Web Publication||13-Mar-2019|
Dr. Ayman Zaky Elsamanoudy
Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Source of Support: None, Conflict of Interest: None
Background and Aim of the Work: The current study postulated that cyclosporine A (CSA) could induce gender-specific renal damage. Hence, the current study aims to investigate the nephrotoxic effect of perinatal exposure of male and female rat progeny to CSA. Moreover, it aims to evaluate the oxidative stress and inflammation as a possible pathophysiologic mechanism. Materials and Methods: Female rats were randomly allocated to two groups of four and assigned to undergo either CSA (15 mg/kg/day; the 6th day after conception and continuing until the progeny were weaned) or vehicle treatment as control groups. At the age of 6 weeks, the progeny were divided into the following four groups: male progeny of control-group mothers (M-vehicle, 7); male progeny of CSA-treated mothers (M-CSA, 9); female progeny of control-group mothers (F-vehicle, 7); and female progeny of CSA-treated mothers (F-CSA, 6). Serum adiponectin, tumor necrosis factor-α (TNF-α) and creatinine, creatinine clearance, and urinary 8-isoprostane were measured. Histopathological examination by hematoxylin and eosin stain of Kidney was carried out. Results: Proteinuria and decreased creatinine clearance are significant in M-CSA than M-vehicle and F-CSA. 8-isoprostane is lower in F-CSA than F-vehicle. Increased TNF-α and decreased adiponectin levels in M-CSA than M-vehicle were observed. No significant differences were found in female rat groups. Conclusion: From the current study, it could be concluded that CSA could induce renal inflammation as well as oxidative stress that may explain the impaired renal function. The sex difference was a prominent finding in their vulnerability to CSA effects.
Keywords: Cyclosporine, gender, inflammation, kidney, oxidative stress, perinatal exposure
|How to cite this article:|
El-Bassossy HM, Hassanien MA, Bima A, Ghoneim FM, Elsamanoudy AZ. Renal oxidative stress and inflammatory response in perinatal Cyclosporine-A exposed rat progeny and its relation to gender. J Microsc Ultrastruct 2019;7:44-9
|How to cite this URL:|
El-Bassossy HM, Hassanien MA, Bima A, Ghoneim FM, Elsamanoudy AZ. Renal oxidative stress and inflammatory response in perinatal Cyclosporine-A exposed rat progeny and its relation to gender. J Microsc Ultrastruct [serial online] 2019 [cited 2019 Mar 20];7:44-9. Available from: http://www.jmau.org/text.asp?2019/7/1/44/254067
| Introduction|| |
Cyclosporine A (CSA) is an immunosuppressant drug. It is commonly used in preventing transplanted organ rejection.,
Its use usually adversely affects the renal systems. It is reported that CSA-induced nephrotoxicity is characterized by hypertension, lower glomerular filtration rate, higher serum creatinine concentration, and decreased creatinine clearance in both rat models, as well as CSA, treated human patients.,,
The exact pathophysiological mechanism of CSA-associated nephrotoxicity is not fully understood until now. Many previous studies proposed oxidative stress and systemic as well as local inflammation as possible underlying mechanisms.,
Pharmacokinetics, pharmacodynamics, and toxicodynamics of CSA had been reported to be dependent on both age and sex. Recently, in 2018, Kim et al. reported that male sex is more prone to CSA nephrotoxic effect than the female sex.
The objectives of the present study were designed:First, to study the possible nephrotoxic effect of perinatal exposure of male and female rat progeny to CSA and elucidate the sex difference. Second, to evaluate the oxidative stress and inflammation as a possible pathophysiologic mechanism.
| Materials and Methods|| |
The present investigation conformed to the Bioethics in Research Regulations implemented by the Kingdom of Saudi Arabia. Male and female Wistar rats that were used for mating were supplied by King Abdulaziz University, the Kingdom of Saudi Arabia. Rats were kept in transparent polypropylene cages with 3–4 rats per cage. The animals had ready access to commercially obtainable rodent food pellets and water and were subjected to constant environmental conditions with equal periods of light and dark.
Experimental design and procedures
In a procedure endorsed by the Ethics Research Committee, King Abdulaziz University, the Kingdom of Saudi Arabia, male and female Wistar rat pairs were placed in individual cages and the date of conception was confirmed by daily vaginal smear testing and weighing. Once pregnant, female rats were randomly allocated to two groups of four and assigned to undergo either CSA or vehicle treatment. CSA group received a dose of 15 mg/kg/day subcutaneously, commencing on the 6th day after conception and continuing until the progeny were weaned., The control group received a vehicle consisting of 18% koliphore and 2% ethanol in sterile saline. At the age of 6 weeks, the progeny was divided into the following four groups: (i) male progeny of control-group mothers (M-vehicle, 7 animals); (ii) male progeny of CSA-treated mothers (M-CSA, 9 animals); (iii) female progeny of control-group mothers (F-vehicle, 7 animals); and (iv) female progeny of CSA-treated mothers (F-CSA, 6 animals).
Then, rats were placed in metabolic cages individually to collect the 24-h urine in order to determine the volume and levels of various parameters such as protein, creatinine and 8-isoprostane, proteinuria, and creatinine clearance. Intraperitoneal injections of ketamine (100 mg/kg) in xylazine (10 mg/kg) were administered to anesthetize the rats before 4 ml of blood were extracted from the vena cava through a small opening in the lower abdomen. This was kept at 4°C for 30 min to coagulate before centrifugation for 20 min at 3,000 g and 4°C. The serum was aspirated, divided into fractions, and stored at −80°C for subsequent tumor necrosis factor-α (TNF-α) and adiponectin analysis. The kidney was fixed in 10% neutral buffered formalin for subsequent histopathological examination by hematoxylin and eosin stain.
ELISA determination was used for the measurements of TNFα (R and D systems®, Minneapolis, MN, USA), adiponectin, and urine 8-isoprostane (Abcam®, Cambridge, MA, USA). Serum creatinine and urine creatinine and protein content were quantified by the ELITech® assay kits (ELITech, Puteaux, France).
Reagents and drugs
Reagents and drugs used in this study were as follows: cyclosporine (Sandimmune®, Novartis Pharmaceuticals Corporation East Hanover, New Jersey), ketamine (Tekam®, Hikma Pharmaceutical, Amman, Jordan), and xylazine (Seton®, Laboratories Calier, Barcelona, Spain) (Sigma-Aldrich, St. Louis, MO, USA).
Statistical variance analysis (ANOVA) was followed by Newman-Keuls post hoc test using statistical software (GraphPad Prism version 5.00 for Windows, GraphPad Software, La Jolla California USA). Values are quoted as the mean ± standard error of the mean and P < 0.05 was considered as statistically significant.
| Results|| |
Influence of perinatal cyclosporine A exposure on kidney function
In the control group, proteinuria was significantly higher in female than in male rats. The administration of CSA (15 mg/kg/day s) to pregnant rats, beginning on the 6th day of conception till weaning, led to a sex-linked kidney dysfunction. CSA administration led to a significant increase in proteinuria in male but not female progeny compared with the corresponding control [Figure 1].
In addition, creatinine clearance was significantly lower in female than in male rats. CSA administration led also to a sex-linked decrease in creatinine clearance in male but not female progeny compared with the corresponding control [Figure 2].
Influence of perinatal cyclosporine A exposure on oxidative stress
No sex-related differences were observed for the oxidative stress marker 8-isoprostane in control groups. However, the female rats subjected to perinatal CSA had significantly reduced amounts of 8-isoprostane. 8-isoprostane was not influenced by perinatal CSA exposure in male progeny [Figure 3].
|Figure 3: Urinary 8-isoprostane level in the studied rats groups (pg/ml)|
Click here to view
Influence of perinatal cyclosporine A exposure on inflammatory/oxidative/fibrotic pathways
In the vehicle-exposed rats, ELISA investigations indicated comparable amounts of the anti-inflammatory (adiponectin) and the inflammatory (TNF-α) cytokines in the serum of male and female rats. Perinatal administration of CSA led to significant decreases in serum adiponectin by approximately 40% in the male progeny with no apparent changes in the female progeny [Figure 4]. Further, ELISA studies showed that perinatally CSA-exposed male, but not female, rats exhibited = 30% increase in serum TNF-α level [Figure 5].
|Figure 5: Serum tumor necrosis factor-α level in the studied rats groups (pg/ml)|
Click here to view
Histopathological effects of perinatal cyclosporine A exposure
While no marked difference between kidney cross-sections from male and female progeny, the perinatal exposure to CSA caused vascular congestion and heavy aggregation of chronic inflammatory cells in male but not female progeny [Figure 6].
|Figure 6: Histopathological findings of kidney tissue of the studied rats groups (H and E stained cross-sections)|
Click here to view
| Discussion|| |
Nephrotoxicity is a well-established common adverse effect of cyclosporine therapy.,,, The renal impairments that are associated with the administration of CSA in experimental rat model are confirmed in the current study in the form of proteinuria, increased serum creatinine level and diminished creatinine clearance. The histopathological examination of the renal tissue proved these biochemical findings. There is evident renal congestion with aggregation of inflammatory cells in the renal tissue. These findings coincide with the previously published results by Lassila et al., Wu et al., Lai et al., and confirmed recently by El-Bassossy and Eid.
The possible mechanisms by which CSA induces nephrotoxicity can be summarized as follow: direct renal tubular apoptosis that is mediated by Fas antigen-ligand system, induction of stress response protein glucose transporter 1 and immunoglobulin A nephrotoxicity with a subsequent development of renal interstitial fibrosis. Renal inflammatory damage could be considered as a strong pathogenic factor of CSA-induced nephrotoxicity.
In the current study, male rats showed an increased level of urinary 8-isoprostane (oxidative stress marker) than the sham control group. Oxidative stress could be a strong pathogenic factor of renal impairment in CSA exposed rats. The role of oxidative stress in the pathogenesis of CSA-induced nephrotoxicity could be explained by many proposed evidence. CSA induces xanthine oxidase activity and increases the production of oxidants. Oxidative stress could induce mitochondrial damage as occurs in CSA-induced hepatotoxicity. Moreover, CSA provokes endoplasmic reticulum (ER) stress and consequently oxidative stress. This was confirmed previously as CSA upregulates expression of ER stress markers especially, immunoglobulin-binding protein, in renal tissue biopsies. Finally, in addition to the increased oxidative stress markers production, CSA administration is associated with a marked decrease in the total antioxidant capacity of the kidneys.,
Mitochondrial and endoplasmic stress is implicated in the pathogenesis of CSA-induced renal impairment., CSA therapy is specifically reported to induce reactive oxygen species production in renal mesangial cells as well as it is also implicated in reducing renal antioxidant defense mechanism. These findings clarify the role of oxidative stress in medicating CSA-induced nephrotoxicity which comes in agreement with the result of the current study.
One of the important findings of the current study in the lowered adiponectin level in 40% of CSA exposed male progeny than the control male rats. This coincides with a study published in 2015 by Sahin et al. They reported that CSA induces higher adiponectin levels, endothelial dysfunction,, and platelet activation without inducing platelet aggregation in their study. Adiponectin levels were elevated as an endothelial damage marker. This hypoadiponectinemia could be considered as a compensatory response to endothelial damage induced by CSA administration.
The anti-inflammatory role of adiponectin is explained by inhibiting endothelial expression of adhesion molecules, suppressing adhesion of the monocytes to the vascular endothelium, so it counteracts the inflammatory response of the endothelium.
While our finding was antagonized previously by Hjelmesaeth et al., They found a negative correlation between CSA administration and adiponectin level, but it did not reach the statistically significant level. They recommended a further investigation to confirm their results, but our study disproves it.
Moreover, TNF-α is found elevated in 30% of CSA exposed male progeny in our study. This in agreement with Schenk et al., They reported that CSA induces the gene expression of renal tissue TNF-α and TNF-α-receptor family ligands as well as soluble form TNF-α receptors at mRNA and protein levels.
CSA-induced TNF-α higher expression could contribute in the induction of ER stress-related apoptosis, and it is enhanced sustained ER stress could induce apoptotic cell death in CsA-mediated renal damage. In addition, it is reported that TNF-α mediates caspase 3/7 activation.
The combined increased TNF-α level and lowered adiponectin level with the histopathological picture of increased aggregation of chronic inflammatory cells in renal tissue could prove the CSA-induced chronic renal inflammatory damage in our study. The inflammatory inducing effect of CSA is previously documented by Segarra Medrano et al., Torres et al., Saito et al., Rodrigues-Diez et al., and Koh et al.
Regarding the sex differences in the investigated biochemical markers in the current study, we confirm in this work, the previously published data in 2018 about the gender-specific CSA-induced renal damage. That is explained by the role that the gonadal hormones play in CSA-induced nephrotoxicity differences in male than female progeny. The explanation of such observation was based on the anti-inflammatory role of both estrogen and testosterone. CSA administration induces reduction of testosterone production in male while it induces an increase in estrogen production in female.
| Conclusion|| |
From the current study, it could be concluded that CSA could induce renal inflammation as well as oxidative stress that may explain the impaired renal function. The oxidative stress in proved by an increased level of urinary 8-isoprostane. The CSA-induced renal inflammatory damage is presented by increased TNF-α and lowered adiponectin level as well as the prominent histopathological inflammatory picture in the form of aggregation of the inflammatory cell with renal vascular congestion. The sex difference was a prominent finding in their vulnerability to CSA effects with male progeny are more affected than female.
This work was supported by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No (D-142-166-1438). The authors, therefore, gratefully acknowledge the DSR technical and financial support.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Kovarik JM, Burtin P. Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases. Expert Opin Emerg Drugs 2003;8:47-62.
El-Bassossy HM, Eid BG. Cyclosporine A exhibits gender-specific nephrotoxicity in rats: Effect on renal tissue inflammation. Biochem Biophys Res Commun 2018;495:468-72.
Gottschalk S, Cummins CL, Leibfritz D, Christians U, Benet LZ, Serkova NJ, et al.
Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism. Neurotoxicology 2011;32:50-7.
Lee CH, Kim S, Kang CM, Kim WY, Kim J, Kim GH, et al.
Altered expression of tight junction proteins in cyclosporine nephrotoxicity. Am J Nephrol 2011;33:7-16.
Damiano S, Trepiccione F, Ciarcia R, Scanni R, Spagnuolo M, Manco L, et al.
Anew recombinant mnSOD prevents the cyclosporine A-induced renal impairment. Nephrol Dial Transplant 2013;28:2066-72.
N' Guessan BB, Sanchez H, Zoll J, Ribera F, Dufour S, Lampert E, et al.
Oxidative capacities of cardiac and skeletal muscles of heart transplant recipients: Mitochondrial effects of cyclosporin-A and its vehicle cremophor-EL. Fundam Clin Pharmacol 2014;28:151-60.
Helmy MW, El-Gowelli HM, Ali RM, El-Mas MM. Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats. Br J Pharmacol 2015;172:4291-302.
Schwartz JB. The current state of knowledge on age, sex, and their interactions on clinical pharmacology. Clin Pharmacol Ther 2007;82:87-96.
Kim BR, Yang S, Doh EJ, Choi CW, Youn SW. Risk factors affecting adverse effects of cyclosporine A in a real-world psoriasis treatment. Ann Dermatol 2018;30:143-9.
El-Mas MM, Afify EA, Omar AG, Sharabi FM. Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J Pharmacol Exp Ther 2002;301:346-54.
El-Mas MM, El-Gowelli HM, Abd-Elrahman KS, Saad EI, Abdel-Galil AG, Abdel-Rahman AA, et al.
Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function. Biochem Pharmacol 2011;81:526-33.
Ponticelli C. Cyclosporine: From renal transplantation to autoimmune diseases. Ann N Y Acad Sci 2005;1051:551-8.
Magnasco A, Rossi A, Catarsi P, Gusmano R, Ginevri F, Perfumo F, et al.
Cyclosporin and organ specific toxicity: Clinical aspects, pharmacogenetics and perspectives. Curr Clin Pharmacol 2008;3:166-73.
El-Gowilly SM. Metoprolol ameliorates cyclosporine a-induced hypertension and nephrotoxicity in rats. J Cardiovasc Pharmacol 2011;58:639-46.
Lassila M, Finckenberg P, Pere AK, Krogerus L, Ahonen J, Vapaatalo H, et al.
Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. Br J Pharmacol 2000;130:1339-47.
Wu Y, Zhang J, Liu F, Yang C, Zhang Y, Liu A, et al.
Protective effects of HBSP on ischemia reperfusion and cyclosporine a induced renal injury. Clin Dev Immunol 2013;2013:758159.
Lai Q, Luo Z, Wu C, Lai S, Wei H, Li T, et al.
Attenuation of cyclosporine A induced nephrotoxicity by schisandrin B through suppression of oxidative stress, apoptosis and autophagy. Int Immunopharmacol 2017;52:15-23.
Rao SR, Sundararajan S, Subbarayan R, Murugan Girija D. Cyclosporine-A induces endoplasmic reticulum stress and influences pro-apoptotic factors in human gingival fibroblasts. Mol Cell Biochem 2017;429:179-85.
Kim SI, Song HY, Hwang JH, Chong DL, Lee HY, Han DS, et al.
Cyclosporine nephrotoxicity: The mechanisms of cell injury by cyclosporine A in renal proximal tubular cells. Transplant Proc 2000;32:1621-2.
Xie L, He J, Liu X, Tang S, Wang W, Li F, et al.
Clinical value of systemic symptoms in IgA nephropathy with ANCA positivity. Clin Rheumatol 2018;37:1953-61.
Wirestam L, Frodlund M, Enocsson H, Skogh T, Wetterö J, Sjöwall C, et al.
Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised swedish cases of SLE. Lupus Sci Med 2017;4:e000225.
Josephine A, Amudha G, Veena CK, Preetha SP, Varalakshmi P. Oxidative and nitrosative stress mediated renal cellular damage induced by cyclosporine A: Role of sulphated polysaccharides. Biol Pharm Bull 2007;30:1254-9.
Korolczuk A, Caban K, Amarowicz M, Czechowska G, Irla-Miduch J. Oxidative stress and liver morphology in experimental cyclosporine A-induced hepatotoxicity. Biomed Res Int 2016;2016:5823271.
Chong WC, Shastri MD, Eri R. Endoplasmic reticulum stress and oxidative stress: A Vicious nexus implicated in bowel disease pathophysiology. Int J Mol Sci 2017;18. pii: E771.
Pallet N, Rabant M, Xu-Dubois YC, Lecorre D, Mucchielli MH, Imbeaud S, et al.
Response of human renal tubular cells to cyclosporine and sirolimus: A toxicogenomic study. Toxicol Appl Pharmacol 2008;229:184-96.
Ghaznavi R, Zahmatkesh M, Kadkhodaee M, Mahdavi-Mazdeh M. Cyclosporine effects on the antioxidant capacity of rat renal tissues. Transplant Proc 2007;39:866-7.
Wu Q, Wang X, Nepovimova E, Wang Y, Yang H, Kuca K, et al.
Mechanism of cyclosporine A nephrotoxicity: Oxidative stress, autophagy, and signalings. Food Chem Toxicol 2018;118:889-907.
Ciarcia R, Damiano S, Florio A, Spagnuolo M, Zacchia E, Squillacioti C, et al.
The protective effect of apocynin on cyclosporine A-induced hypertension and nephrotoxicity in rats. J Cell Biochem 2015;116:1848-56.
O'Connell S, Slattery C, Ryan MP, McMorrow T. Identification of novel indicators of cyclosporine A nephrotoxicity in a CD-1 mouse model. Toxicol Appl Pharmacol 2011;252:201-10.
Sahin G, Akay OM, Uslu S, Bal C, Yalcin AU, Gulbas Z, et al.
Association between endothelial and platelet function markers and adiponectin in renal transplanted recipients on cyclosporine and tacrolimus immunosuppression based therapy. Nephrology (Carlton) 2015;20:392-8.
Calò L, Semplicini A, Davis PA, Bonvicini P, Cantaro S, Rigotti P, et al.
Cyclosporin-induced endothelial dysfunction and hypertension: Are nitric oxide system abnormality and oxidative stress involved? Transpl Int 2000;13 Suppl 1:S413-8.
Shimabukuro M, Higa N, Asahi T, Oshiro Y, Takasu N, Tagawa T, et al.
Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin Endocrinol Metab 2003;88:3236-40.
Sahin G, Akay OM, Kus E, Bal C, Yalcin AU, Gulbas Z, et al.
Effects of immunosuppressive drugs on platelet aggregation and soluble P-selectin levels in renal transplant patients. Ren Fail 2009;31:111-7.
Hjelmesaeth J, Flyvbjerg A, Jenssen T, Frystyk J, Ueland T, Hagen M, et al.
Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: Impact of immunosuppressive and antihypertensive drug therapy. Clin J Am Soc Nephrol 2006;1:575-82.
Schenk LK, Rinschen MM, Klokkers J, Kurian SM, Neugebauer U, Salomon DR, et al.
Cyclosporin-A induced toxicity in rat renal collecting duct cells: Interference with enhanced hypertonicity induced apoptosis. Cell Physiol Biochem 2010;26:887-900.
Hu P, Han Z, Couvillon AD, Kaufman RJ, Exton JH. Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol Cell Biol 2006;26:3071-84.
Han SW, Li C, Ahn KO, Lim SW, Song HG, Jang YS, et al.
Prolonged endoplasmic reticulum stress induces apoptotic cell death in an experimental model of chronic cyclosporine nephropathy. Am J Nephrol 2008;28:707-14.
Al-Lamki RS, Wang J, Tolkovsky AM, Bradley JA, Griffin JL, Thiru S, et al.
TL1A both promotes and protects from renal inflammation and injury. J Am Soc Nephrol 2008;19:953-60.
Segarra Medrano A, Vila Presas J, Pou Clavé L, Majó Masferrer J, Camps Doménech J. Efficacy and safety of combined cyclosporin A and mycophenolate mofetil therapy in patients with cyclosporin-resistant focal segmental glomerulosclerosis. Nefrologia 2011;31:286-91.
Torres IB, Moreso F, Sarró E, Meseguer A, Serón D. The interplay between inflammation and fibrosis in kidney transplantation. Biomed Res Int 2014;2014:750602.
Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, et al.
Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: A randomized controlled multicenter trial. Clin Exp Nephrol 2014;18:784-94.
Rodrigues-Diez R, González-Guerrero C, Ocaña-Salceda C, Rodrigues-Diez RR, Egido J, Ortiz A, et al.
Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling. Sci Rep 2016;6:27915.
Koh ES, Kim S, Kim M, Hong YA, Shin SJ, Park CW, et al.
DPinitol alleviates cyclosporine Ainduced renal tubulointerstitial fibrosis via activating Sirt1 and Nrf2 antioxidant pathways. Int J Mol Med 2018;41:1826-34.
Yao X, Wigginton JG, Maass DL, Ma L, Carlson D, Wolf SE, et al.
Estrogen-provided cardiac protection following burn trauma is mediated through a reduction in mitochondria-derived DAMPs. Am J Physiol Heart Circ Physiol 2014;306:H882-94.
El-Mas MM, Afify EA, Omar AG, Mohy El-Din MM, Sharabi FM. Testosterone depletion contributes to cyclosporine-induced chronic impairment of acetylcholine renovascular relaxations. Eur J Pharmacol 2003;468:217-24.
Petraitiene R, Petraitis V, Bacher J, Das SR, Parlow AF, Walsh TJ, et al.
Cyclosporine A-induced mammary hyperplasia and hyperprolactinemia in New Zealand white rabbits. Comp Med 2001;51:430-5.
[Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6]